common.study.topics.clinical

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

common.study.values.description

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Diagnostic Test - MRI with DBSI technology

The MRI will be done with diffusion basis spectrum imaging

participant.views.study.view.additional

participant.views.study.view.scientific-title

Predictive Value of Diffusion MRI in Cervical Spondylotic Myelopathy

common.study.values.clinical-trial-id

NCT03296592

participant.views.study.view.id

1aMGQd